AIM
CRL icon

Anchor Investment Management’s Charles River Laboratories CRL Stock Holding History

Anchor Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.58K Hold
29
– – ﹤0.01% 950
2026
Q1 		$5K Hold
29
– – ﹤0.01% 898
2025
Q4 		$5.79K Hold
29
– – ﹤0.01% 883
2025
Q3 		$4.54K Sell
29
-2
-6% -$318 ﹤0.01% 915
2025
Q2 		$4.7K Hold
31
– – ﹤0.01% 895
2025
Q1 		$4.67K Hold
31
– – ﹤0.01% 890
2024
Q4 		$5.72K Hold
31
– – ﹤0.01% 865
2024
Q3 		$6.11K Hold
31
– – ﹤0.01% 857
2024
Q2 		$6.4K Hold
31
– – ﹤0.01% 813
2024
Q1 		$8.4K Buy
+31
New +$7.4K ﹤0.01% 808

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Anchor Investment Management's CRL Position: Q2 2026 in Review

Anchor Investment Management held its Charles River Laboratories (CRL) position steady in Q2 2026 at 29 shares worth $6.58K. The position accounts for ﹤0.01% of the portfolio, ranked #950.

Anchor Investment Management first reported a position in CRL in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.4K in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Anchor Investment Management held 29 shares of Charles River Laboratories worth $6.58K as of Q2 2026.
  • Anchor Investment Management left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Anchor Investment Management's portfolio in Q2 2026, its #950 holding.
  • Anchor Investment Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Anchor Investment Management's Charles River Laboratories position peaked at $8.4K in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Anchor Investment Management's 13F filing for Q2 2026, filed 15 Sep 2026.